Treatment of anxiety disorders with venlafaxine XR.

about

Early detection and treatment of panic disorder with or without agoraphobia: update Pharmacotherapy of PTSD: premises, principles, and priorities Inhibition of the G9a/GLP histone methyltransferase complex modulates anxiety-related behavior in mice.

P2860

Q24653681-B9C0FC3E-BB5D-49E9-89C7-DC1E266961B5 Q30479154-938C6671-E305-42E9-8BE9-1DCDEF478AC6 Q50123806-14B4BEE7-CFA4-41D6-8D8A-425C2294113D

P2860

Treatment of anxiety disorders with venlafaxine XR.

Item

http://www.wikidata.org/entity/Q36419538

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Treatment of anxiety disorders with venlafaxine XR.

@ast

Treatment of anxiety disorders with venlafaxine XR.

@en

type

Item

label

Treatment of anxiety disorders with venlafaxine XR.

@ast

Treatment of anxiety disorders with venlafaxine XR.

@en

prefLabel

Treatment of anxiety disorders with venlafaxine XR.

@ast

Treatment of anxiety disorders with venlafaxine XR.

@en

P1476

Treatment of anxiety disorders with venlafaxine XR.

@en

P2093

Michael E Thase

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data.

Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data.

Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.

What is a "mood stabilizer"? An evidence-based response.

A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder.

Neuropharmacology of venlafaxine.

Review of the pharmacokinetics, pharmacogenetics, and drug interaction potential of antidepressants: focus on venlafaxine.

Efficacy of venlafaxine in mixed depression-anxiety states.

P304

269-282

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737175.6.3.269

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16533131

http://www.w3.org/2001/XMLSchema#string

Treatment of anxiety disorders with venlafaxine XR.

about

P2860

P2860

Treatment of anxiety disorders with venlafaxine XR.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698